 CAMBRIDGE, Mass.--BUSINESS WIRE--Magenta Therapeutics NASDAQ: MGTA, a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune and blood systems reset via stem cell transplant to more patients, today announced data presentations across its stem cell mobilization and targeted conditioning programs at the Transplantation and Cellular Therapy TCT Annual Meeting, to be held virtually on February 8-12, 2021. Magenta continues to generate encouragin 